Patents by Inventor Bahram Arezi

Bahram Arezi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10711269
    Abstract: A method for making an asymmetrically-tagged sequencing library is provided. In some embodiments, the method may comprise: obtaining a symmetrically-tagged library of cDNA or genomic DNA fragments, hybridizing a tailed first primer to the 3? sequence tag of the library and extending the same to produce primer extension products, and amplifying the primer extension products using a pair of tailed primers to produce asymmetrically-tagged library.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: July 14, 2020
    Assignee: Agilent Technologies, Inc.
    Inventors: Brian Jon Peter, David Taussig, Bahram Arezi, Robert A. Ach, Nicholas M. Sampas
  • Patent number: 10240196
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: March 26, 2019
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen
  • Publication number: 20180201924
    Abstract: A method for making an asymmetrically-tagged sequencing library is provided. In some embodiments, the method may comprise: obtaining a symmetrically-tagged library of cDNA or genomic DNA fragments, hybridizing a tailed first primer to the 3? sequence tag of the library and extending the same to produce primer extension products, and amplifying the primer extension products using a prior of tailed primers to produce asymmetrically-tagged library.
    Type: Application
    Filed: January 18, 2017
    Publication date: July 19, 2018
    Inventors: Brian Jon Peter, David Taussig, Bahram Arezi, Robert A. Ach, Nicholas M. Sampas
  • Publication number: 20170342483
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Application
    Filed: May 27, 2016
    Publication date: November 30, 2017
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen
  • Patent number: 9783791
    Abstract: The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: October 10, 2017
    Assignee: Agilent Technologies, Inc.
    Inventors: Holly Hogrefe, Bahram Arezi, Weimei Xing
  • Patent number: 9758773
    Abstract: The invention provides mutants of DNA polymerases having an enhanced resistance to inhibitors of DNA polymerase activity. The mutant polymerases are well suited for PCR amplification of targets in samples that contain inhibitors of wild-type polymerases.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: September 12, 2017
    Assignee: Agilent Technologies, Inc.
    Inventors: Nancy Mckinney, Holly H. Hogrefe, Jeffrey Fox, Connie J. Hansen, Bahram Arezi
  • Patent number: 9523085
    Abstract: The present invention provides mutants of DNA polymerases having an increased rate of incorporation of nucleotides into nucleic acids undergoing polymerization and having an enhanced resistance to inhibitors of DNA polymerase activity. The mutant polymerases are well suited for fast PCR applications, for PCR amplification of targets in samples that contain inhibitors of wild-type polymerases, and for fast PCR amplification of samples containing DNA polymerase inhibitors. In exemplary embodiments, the mutants are mutants of Taq DNA polymerase.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: December 20, 2016
    Assignee: Agilent Technologies Inc.
    Inventors: Holly Hogrefe, Michelle Cayouette, Jeffrey Fox, Connie J. Hansen, Jennifer Lapira, Bahram Arezi, Nancy McKinney
  • Publication number: 20160340657
    Abstract: The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.
    Type: Application
    Filed: April 4, 2016
    Publication date: November 24, 2016
    Applicant: Agilent Technologies, Inc.
    Inventors: Holly H. Hogrefe, Bahram Arezi, Weimei Xing
  • Publication number: 20150232821
    Abstract: The invention provides mutants of DNA polymerases having an enhanced resistance to inhibitors of DNA polymerase activity. The mutant polymerases are well suited for PCR amplification of targets in samples that contain inhibitors of wild-type polymerases.
    Type: Application
    Filed: December 12, 2014
    Publication date: August 20, 2015
    Applicant: AGILENT TECHNOLOGIES, INC.
    Inventors: Nancy Mckinney, Holly H. Hogrefe, Jeffrey Fox, Connie J. Hansen, Bahram Arezi
  • Publication number: 20110027833
    Abstract: The present invention provides mutants of DNA polymerases having an increased rate of incorporation of nucleotides into nucleic acids undergoing polymerization and having an enhanced resistance to inhibitors of DNA polymerase activity. The mutant polymerases are well suited for fast PCR applications, for PCR amplification of targets in samples that contain inhibitors of wild-type polymerases, and for fast PCR amplification of samples containing DNA polymerase inhibitors. In exemplary embodiments, the mutants are mutants of Taq DNA polymerase.
    Type: Application
    Filed: August 2, 2010
    Publication date: February 3, 2011
    Inventors: Holly Hogrefe, Michelle Cayouette, Jeffrey Fox, Connie J. Hansen, Jennifer Lapira, Bahram Arezi, Nancy McKinney
  • Publication number: 20080227661
    Abstract: The invention relates to the generation and characterization of stable MMLV reverse transcriptase mutants. The invention also discloses methods of using stable MMLV reverse transcriptase mutants.
    Type: Application
    Filed: August 10, 2006
    Publication date: September 18, 2008
    Inventors: Holly Hogrefe, Bahram Arezi, Weimei Xing
  • Publication number: 20050272074
    Abstract: The present invention provides compositions and methods for high fidelity cDNA synthesis. In particular, the composition of the present invention contains a first enzyme exhibiting a reverse transcriptase activity and a second enzyme comprising a 3?-5? exonuclease activity.
    Type: Application
    Filed: April 6, 2005
    Publication date: December 8, 2005
    Inventor: Bahram Arezi
  • Publication number: 20050123940
    Abstract: The present invention relates to composition, kits and methods comprising a mutant DNA polymerase exhibiting increased reverse transcriptase activity. The invention also relates to methods of generating modified cDNA.
    Type: Application
    Filed: May 26, 2004
    Publication date: June 9, 2005
    Inventors: Joseph Sorge, Holly Hogrefe, Connie Hansen, Bahram Arezi, Rebecca Mullinax
  • Publication number: 20050118609
    Abstract: The present invention relates to a method for identifying a nucleotide at a predetermined location on a target polynucleotide. The method involves single nucleotide extension reaction comprising an oligonucleotide primer comprising a first sequence and a second sequence or a tag. The method may further comprises a probe which hybridizes to the second sequence or an anti-tag molecule which interacts with the tag, where the hybridization or interaction causes a detectable signal transfer which is indicative of the identity of the nucleotide base at the predetermined location. The invention further provides compositions and kits for performing the subject method of the invention.
    Type: Application
    Filed: June 4, 2004
    Publication date: June 2, 2005
    Inventors: Joseph Sorge, Bahram Arezi, Holly Hogrefe
  • Patent number: 6803201
    Abstract: The present invention relates to a method for identifying a nucleotide at a predetermined location on a target polynucleotide. The method involves single nucleotide extension reaction comprising an oligonucleotide primer comprising a first sequence and a second sequence or a tag. The method may further comprises a probe which hybridizes to the second sequence or an anti-tag molecule which interacts with the tag, where the hybridization or interaction causes a detectable signal transfer which is indicative of the identity of the nucleotide base at the predetermined location. The invention further provides compositions and kits for performing the subject method of the invention.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: October 12, 2004
    Assignee: Stratagene
    Inventors: Joseph A. Sorge, Bahram Arezi, Holly Hogrefe
  • Publication number: 20030228616
    Abstract: The present invention relates to compositions and kits comprising a mutant DNA polymerase with increased reverse transcriptase activity. The invention also relates to methods for using the subject compositions and kits.
    Type: Application
    Filed: May 12, 2003
    Publication date: December 11, 2003
    Applicant: Stratagene
    Inventors: Bahram Arezi, Holly Hogrefe, Joseph A. Sorge, Connie Jo Hansen
  • Publication number: 20030149257
    Abstract: The present invention relates to a method for identifying a nucleotide at a predetermined location on a target polynucleotide. The method involves single nucleotide extension reaction comprising an oligonucleotide primer comprising a first sequence and a second sequence or a tag. The method may further comprises a probe which hybridizes to the second sequence or an anti-tag molecule which interacts with the tag, where the hybridization or interaction causes a detectable signal transfer which is indicative of the identity of the nucleotide base at the predetermined location. The invention further provides compositions and kits for performing the subject method of the invention.
    Type: Application
    Filed: January 24, 2002
    Publication date: August 7, 2003
    Applicant: Stratagene
    Inventors: Joseph A. Sorge, Bahram Arezi, Holly Hogrefe
  • Patent number: RE49207
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: September 13, 2022
    Assignee: Agilent Technologies, Inc.
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen